Recent Finacing
Recent Raise
FEMSelect develops EnPlace, an FDA-cleared, minimally invasive, meshless pelvic-floor ligament fixation system for symptomatic uterine prolapse, enabling sub-30-minute procedures with rapid patient recovery and multi-state US availability.
